Radiation for Hodgkin’s disease puts women at greater risk for breast cancer
Women exposed to radiation therapy for Hodgkin’s disease have a relative risk 7.7 times greater than the general population of developing breast cancer, according to a study presented at the European Congress of Radiology in Vienna, in March.
Women exposed to radiation therapy for Hodgkin’s disease have a relative risk 7.7 times greater than the general population of developing breast cancer, according to a study presented at the European Congress of Radiology in Vienna, in March.
European Congress of Radiology in Vienna, in March. Dr. Andrea Luparia, from the University of Torino in Italy, and colleagues retrospectively studied 43 women treated with radiation therapy for Hodgkin’s disease between 1980 and 2009. Six invasive breast cancers were detected by mammography in five of the 43 women. Breast cancer was diagnosed following a median latent period from radiotherapy of 13.3 years. Average radiation dose was 33.6 Gy while in women who developed breast cancer it was 37.9 Gy.
For women treated for Hodgkin’s disease with radiation therapy, no-dose breast imaging options should be considered, the authors said. Of women with high-density breasts, those younger than 30 should be monitored with ultrasound and MR. Those older than 30 should be monitored with ultrasound, mammography, and MR.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Mammography Study: AI Facilitates Greater Accuracy and Longer Fixation Time on Suspicious Areas
July 8th 2025While noting no differences in sensitivity, specificity or reading time with adjunctive AI for mammography screening, the authors of a new study noted a 4 percent higher AUC and increased fixation time on lesion regions.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.
